Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type
Clinical trial NCT02249351 · TERMINATED
Trial details
- NCT number
- NCT02249351
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
- Primary completion
- 2000-05-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.